Report Highlights
The global market for ophthalmic devices, diagnostics, and surgical equipment was valued at nearly $16.9 billion in 2012, up from $16.2 billion in 2011. The market is expected to reach $20.2 billion in 2017, an increase of nearly $3.4 billion during the forecast period and a compound annual growth rate (CAGR) of 3.7% from 2012 to 2017.
Report Includes
- An overview of the global markets for ophthalmic devices, diagnostics, and surgery
- Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Identification of products by product type and, where applicable, by disease type
- Examination of general areas identified with appropriate subsegments, including imaging equipment and nonimaging exam diagnostics, the contact lens market, the surgical market, and intraocular lenses, shunts and other drainage devices
- Discussion in terms of use, with a focus on specific diseases and conditions such as cataract treatments, glaucoma treatments, and refractive treatments; each segment provides detailed information of products, current market estimates, and market forecasts
- Comprehensive company profiles of major players in the industry.
SCOPE AND FORMAT
This BCC report is designed to be a helpful business tool to provide a thorough evaluation of the ophthalmic device, diagnostic and surgical market. The geographical scope is worldwide, with an emphasis on major markets such as the United States. This report identifies products by product type and, where applicable, by disease type.
Within the global market of ophthalmic devices, diagnostics and surgical equipment, three general areas are identified, with appropriate subsegments discussed. These include:
- Ophthalmic diagnostic market.
- Ophthalmic imaging equipment.
- Nonimaging exam diagnostics.
- Other diagnostic equipment and peripherals.
- Contact lens market.
- Soft lenses.
- Gas permeable lenses.
- Cosmetic lenses.
- Shaping lenses.
- Ophthalmic surgical market.
- Ophthalmic lasers, phacoemulsification systems and related equipment.
- Intraocular lenses.
- Shunts and other drainage devices.
- Other surgical devices and equipment.
Additionally, the market is analyzed in terms of use and focuses on specific diseases and conditions such as cataract treatments, glaucoma treatments and refractive treatments. Each segment provides detailed information of products, current market estimates and market forecasts.
Analyst Credentials
Melissa Elder is an experienced healthcare market analyst specializing in medical treatments, equipment and devices. Ms. Elder holds an MBA in Health Care Management and provides consultation to various institutions globally. She has been involved in the healthcare industry since 1996, providing more than 23 years of industry expertise. Ms. Elder has specialized in market research for more than 20 years, focusing on the areas of advanced medical technologies, biological products and animal health. In-depth analysis into more than 100 health-related topics has given Ms. Elder substantial insight into industry dynamics, market influences and future direction of various health markets. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare specialties. She has authored several industry-specific documents and is a well-respected contributor to the market research community. Her writings are published in magazines, newspapers and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents.
Report Highlights
- The global market for ophthalmic devices, diagnostics, and surgical equipment was valued at $15.2 billion in 2009, up from $13.5 billion in 2007. The market is estimated to reach $19 billion in 2014, an increase of nearly $4 billion over the forecast period and a compound annual growth rate (CAGR) of 4.6% from 2009 to 2014.
- Contact lenses, including both functional and cosmetic lenses, account for 43% of the worldwide market. This segment was worth $6.6 billion in 2009 and is expected to increase to $7.7 billion in 2014, a compound annual growth rate (CAGR) of 3.3%.
- Surgical equipment generated a market worth $5.5 billion in 2009, accounting for 36% of the total market. By 2014, this sector will be valued at an estimated $7.3 billion, a compound annual growth rate (CAGR) of 5.9%.
Related Reports
Global Markets for Animal Therapeutics and Diagnostics
The total market for animal therapeutics and diagnostics was $30 billion in 2011, up from $25 billion in 2008. By 2016, this market is likely to exceed $42 billion, with a five-year compound annual growth rate (CAGR) of 7.2% from 2011 through 2016.
Digital Photography: Global Markets
The global digital photography market was valued at $65.6 billion in 2010 and $68.4 billion in 2011. By 2016, the digital photography market should reach $82.5 billion, a 3.8% compound annual growth rate (CAGR) between 2011 and 2016.
Optical Coatings: Technologies and Global Markets
The global market value of optical coatings reached nearly $6 billion in 2010 and nearly $6.7 billion in 2011. It is expected to reach $10.2 billion by 2016, a compound annual growth rate (CAGR) of 8.7%.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More